Effectiveness and tolerability of citalopram for the treatment of depression and anxiety disorders in children and adolescents: An open-label study

Journal of Neural Transmission

Volumn 117, Issue 1, 2010, Pages 139-145

  Schirman, Shella ^a,b   Kronenberg, Sefi ^a   Apter, Alan ^a   Brent, David ^c   Melhem, Nadine ^c   Pick, Nimrod ^a   Carmel, Miri ^a   Frisch, Amos ^a   Weizman, Abraham ^a   Gothelf, Doron ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b GOETHE UNIVERSITY   (Germany)

^c UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Antidepressants; Anxiety disorders; Depression; Mood disorders; Selective serotonin reuptake inhibitors; Suicidality

Indexed keywords

CITALOPRAM;

ADOLESCENT; ADULT; AGITATION; ANXIETY DISORDER; ARTICLE; CHILD; CLINICAL GLOBAL IMPRESSION SCALE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DECREASED APPETITE; DEPRESSION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FATIGUE; FEMALE; HEADACHE; HUMAN; HYPERSOMNIA; INSOMNIA; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PRIORITY JOURNAL; RATING SCALE; SCHOOL CHILD; SIDE EFFECT; STOMACH DISCOMFORT; SUICIDE ATTEMPT; SWEATING; TREATMENT RESPONSE;

ADOLESCENT; ANTI-ANXIETY AGENTS; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; ANXIETY DISORDERS; CHILD; CITALOPRAM; COMORBIDITY; DEPRESSIVE DISORDER; FEMALE; HUMANS; MALE; PSYCHIATRIC STATUS RATING SCALES; TIME FACTORS; TREATMENT OUTCOME;

EID: 76949095648     PISSN: 03009564     EISSN: 14351463     Source Type: Journal    
DOI: 10.1007/s00702-009-0330-x     Document Type: Article

References (49)

1. PJ Ambrosini C Metz MD Bianchi H Rabinovich A Undie 1991 Concurrent validity and psychometric properties of the Beck Depression Inventory in outpatient adolescents J Am Acad Child Adolesc Psychiatry 30 51 57 10.1097/00004583-199101000-00008 1:STN:280:DyaK3M7ntVWgsA%3D%3D 2005064
2. PJ Ambrosini KD Wagner J Biederman I Glick C Tan J Elia JR Hebeler H Rabinovich J Lock D Geller 1999 Multicenter open-label sertraline study in adolescent outpatients with major depression J Am Acad Child Adolesc Psychiatry 38 566 572 10.1097/00004583-199905000-00018 1:STN:280:DyaK1M3ks1yjsQ%3D%3D 10230188
3. A Apter S Kronenberg D Brent 2005 Turning darkness into light. A new landmark study on the treatment of adolescent depression. Comments on the TADS study Eur Child Adolesc Psychiatry 14 113 116 10.1007/s00787-005-0474-7 15959656
4. JL Baumgartner GJ Emslie ML Crismon 2002 Citalopram in children and adolescents with depression or anxiety Ann Pharmacother 36 1692 1697 10.1345/aph.1C078 1:CAS:528:DC%2BD38XovFamt7s%3D 12398561
5. CM Beasley Jr BE Dornseif JC Bosomworth ME Sayler AH Rampey Jr JH Heiligenstein VL Thompson DJ Murphy DN Masica 1991 Fluoxetine and suicide: a meta-analysis of controlled trials of treatment for depression BMJ 303 685 692 10.1136/bmj.303.6804.685 1833012
6. GA Bernstein K Shaw 1997 Practice parameters for the assessment and treatment of children and adolescents with anxiety disorders American Academy of Child and Adolescent Psychiatry J Am Acad Child Adolesc Psychiatry 36 69S 84S 1:STN:280:DyaK2svnsV2ntw%3D%3D 9334566
7. B Birmaher S Khetarpal D Brent M Cully L Balach J Kaufman SM Neer 1997 The Screen for Child Anxiety Related Emotional Disorders (SCARED): scale construction and psychometric characteristics J Am Acad Child Adolesc Psychiatry 36 545 553 10.1097/00004583-199704000-00018 1:STN:280:DyaK2s3lsFSltw%3D%3D 9100430
8. B Birmaher DA Brent L Chiappetta J Bridge S Monga M Baugher 1999 Psychometric properties of the Screen for Child Anxiety Related Emotional Disorders (SCARED): a replication study J Am Acad Child Adolesc Psychiatry 38 1230 1236 10.1097/00004583-199910000-00011 1:STN:280:DyaK1Mvks1amsA%3D%3D 10517055
9. B Birmaher DA Axelson K Monk C Kalas DB Clark M Ehmann J Bridge J Heo DA Brent 2003 Fluoxetine for the treatment of childhood anxiety disorders J Am Acad Child Adolesc Psychiatry 42 415 423 12649628
10. DA Brent 1993 Depression and suicide in children and adolescents Pediatr Rev 14 380 388 10.1542/pir.14-10-380 1:STN:280:DyaK2c%2FnslOrtg%3D%3D 8255818
11. JA Bridge S Iyengar CB Salary RP Barbe B Birmaher HA Pincus L Ren DA Brent 2007 Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment: a meta-analysis of randomized controlled trials JAMA 297 1683 1696 10.1001/jama.297.15.1683 1:CAS:528:DC%2BD2sXksVChsL4%3D 17440145 (Pubitemid 46631627)
12. SN Compton PJ Grant AK Chrisman PJ Gammon VL Brown JS March 2001 Sertraline in children and adolescents with social anxiety disorder: an open trial J Am Acad Child Adolesc Psychiatry 40 564 571 10.1097/00004583-200105000- 00016 1:STN:280:DC%2BD3M3ltFeqtw%3D%3D 11349701
13. GJ Emslie AJ Rush WA Weinberg RA Kowatch CW Hughes T Carmody J Rintelmann 1997 A double-blind, randomized, placebo-controlled trial of fluoxetine in children and adolescents with depression Arch Gen Psychiatry 54 1031 1037 1:CAS:528:DyaK2sXntlygsbw%3D 9366660
14. GJ Emslie AJ Rush WA Weinberg RA Kowatch T Carmody TL Mayes 1998 Fluoxetine in child and adolescent depression: acute and maintenance treatment Depress Anxiety 7 32 39 10.1002/(SICI)1520-6394(1998)7:1<32::AID-DA4>3.0. CO;2-7 1:STN:280:DyaK1c3lsV2rsQ%3D%3D 9592630 (Pubitemid 28248517)
15. GJ Emslie JH Heiligenstein KD Wagner SL Hoog DE Ernest E Brown M Nilsson JG Jacobson 2002 Fluoxetine for acute treatment of depression in children and adolescents: a placebo-controlled, randomized clinical trial J Am Acad Child Adolesc Psychiatry 41 1205 1215 10.1097/00004583-200210000-00010 12364842 (Pubitemid 38338040)
16. GJ Emslie ND Ryan KD Wagner 2005 Major depressive disorder in children and adolescents: clinical trial design and antidepressant efficacy J Clin Psychiatry 66 Suppl 7 14 20 1:CAS:528:DC%2BD2MXhtFSksbrL 16124837
17. G Emslie C Kratochvil B Vitiello S Silva T Mayes S McNulty E Weller B Waslick C Casat J Walkup S Pathak P Rohde K Posner J March 2006 Treatment for Adolescents with Depression Study (TADS): safety results J Am Acad Child Adolesc Psychiatry 45 1440 1455 10.1097/01.chi.0000240840.63737.1d 17135989 (Pubitemid 44900917)
18. GJ Emslie KD Wagner S Kutcher S Krulewicz R Fong DJ Carpenter A Lipschitz A Machin C Wilkinson 2006 Paroxetine treatment in children and adolescents with major depressive disorder: a randomized, multicenter, double-blind, placebo-controlled trial J Am Acad Child Adolesc Psychiatry 45 709 719 10.1097/01.chi.0000214189.73240.63 16721321 (Pubitemid 43833104)
19. JM Fairbanks DS Pine NK Tancer ES Dummit 3rd LM Kentgen J Martin BK Asche RG Klein 1997 Open fluoxetine treatment of mixed anxiety disorders in children and adolescents J Child Adolesc Psychopharmacol 7 17 29 10.1089/cap.1997.7.17 1:STN:280:DyaK2szis1yltQ%3D%3D 9192539
20. D Fergusson S Doucette KC Glass S Shapiro D Healy P Hebert B Hutton 2005 Association between suicide attempts and selective serotonin reuptake inhibitors: systematic review of randomised controlled trials BMJ 330 396 10.1136/bmj.330.7488.396 1:CAS:528:DC%2BD2MXisVOrtLk%3D 15718539
21. Guy W (1976) Clinical global improvement scale. In: Assessment manual of psychopharmacology. National Institute of Mental Health, Rockville
22. JD Hamilton J Bridge 1999 Outcome at 6 months for 50 adolescents with major depression treated in a health maintenance organization J Am Acad Child Adolesc Psychiatry 38 1340 1346 1:STN:280:DC%2BD3c%2FisVSjuw%3D%3D 10560219
23. TA Hammad T Laughren J Racoosin 2006 Suicidality in pediatric patients treated with antidepressant drugs Arch Gen Psychiatry 63 332 339 10.1001/archpsyc.63.3.332 1:CAS:528:DC%2BD28XislGis7Y%3D 16520440 (Pubitemid 43345358)
24. A Hemeryck FM Belpaire 2002 Selective serotonin reuptake inhibitors and cytochrome P-450 mediated drug-drug interactions: an update Curr Drug Metab 3 13 37 10.2174/1389200023338017 1:CAS:528:DC%2BD38XhvFKmtb4%3D 11876575 (Pubitemid 34296308)
25. SS Jick AD Dean H Jick 1995 Antidepressants and suicide BMJ 310 215 218 1:STN:280:DyaK2M7ntVCjtg%3D%3D 7677826
26. H Jick JA Kaye SS Jick 2004 Antidepressants and the risk of suicidal behaviors JAMA 292 338 343 10.1001/jama.292.3.338 1:CAS:528:DC%2BD2cXlvFaju7g%3D 15265848 (Pubitemid 38944257)
27. J Kaufman B Birmaher D Brent U Rao C Flynn P Moreci D Williamson N Ryan 1997 Schedule for affective disorders and schizophrenia for school-age children-present and lifetime version (K-SADS-PL): initial reliability and validity data J Am Acad Child Adolesc Psychiatry 36 980 988 10.1097/00004583- 199707000-00021 1:STN:280:DyaK2szkvVKqsQ%3D%3D 9204677
28. MB Keller 2000 Citalopram therapy for depression: a review of 10 years of European experience and data from U.S. clinical trials J Clin Psychiatry 61 896 908 1:CAS:528:DC%2BD3MXhtVChtrw%3D 11206593
29. MB Keller ND Ryan M Strober RG Klein SP Kutcher B Birmaher OR Hagino H Koplewicz GA Carlson GN Clarke GJ Emslie D Feinberg B Geller V Kusumakar G Papatheodorou WH Sack M Sweeney KD Wagner EB Weller NC Winters R Oakes JP McCafferty 2001 Efficacy of paroxetine in the treatment of adolescent major depression: a randomized, controlled trial J Am Acad Child Adolesc Psychiatry 40 762 772 10.1097/00004583-200107000-00010 1:STN:280:DC%2BD3MzotVehtA%3D%3D 11437014
30. B Kennard S Silva B Vitiello J Curry C Kratochvil A Simons J Hughes N Feeny E Weller M Sweeney M Reinecke S Pathak G Ginsburg G Emslie J March 2006 Remission and residual symptoms after short-term treatment in the Treatment of Adolescents with Depression Study (TADS) J Am Acad Child Adolesc Psychiatry 45 1404 1411 10.1097/01.chi.0000242228.75516.21 17135985 (Pubitemid 44900913)
31. A Khan S Khan R Kolts WA Brown 2003 Suicide rates in clinical trials of SSRIs, other antidepressants, and placebo: analysis of FDA reports Am J Psychiatry 160 790 792 10.1176/appi.ajp.160.4.790 12668373 (Pubitemid 41079617)
32. S Kronenberg A Apter D Brent S Schirman N Melhem N Pick D Gothelf M Carmel A Frisch A Weizman 2007 Serotonin transporter polymorphism (5-HTTLPR) and citalopram effectiveness and side effects in children with depression and/or anxiety disorders J Child Adolesc Psychopharmacol 17 741 750 10.1089/cap.2006.0144 18315446 (Pubitemid 351158594)
33. CJ Lim JF Leckman C Young A Martin 2005 Antidepressant-induced manic conversion: a developmentally informed synthesis of the literature Int Rev Neurobiol 65 25 52 10.1016/S0074-7742(04)65002-1 1:CAS:528:DC%2BD28Xot1Grsrg%3D 16140052
34. I Lucki OF O'Leary 2004 Distinguishing roles for norepinephrine and serotonin in the behavioral effects of antidepressant drugs J Clin Psychiatry 65 Suppl 4 11 24 1:CAS:528:DC%2BD2cXjs1Cit7k%3D 15046537
35. J March S Silva S Petrycki J Curry K Wells J Fairbank B Burns M Domino S McNulty B Vitiello J Severe 2004 Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents With Depression Study (TADS) randomized controlled trial JAMA 292 807 820 10.1001/jama.292.21.2578-c 1:CAS:528:DC%2BD2cXmvFCnsLo%3D 15315995 (Pubitemid 39079667)
36. E Poznanski LN Freeman H Mokros 1985 Children's depression rating scale-revised J Psychopharmacol Bull 21 979 989
37. Reynolds W (1987) Suicide ideation questionnaire. Psychological Assessment Resources, Odessa
38. N Shanee A Apter A Weizman 1997 Psychometric properties of the K-SADS-PL in an Israeli adolescent clinical population Isr J Psychiatry Relat Sci 34 179 186 1:STN:280:DyaK2svnsV2jsw%3D%3D 9334522
39. E Shirazi J Alaghband-Rad 2005 An open trial of citalopram in children and adolescents with depression J Child Adolesc Psychopharmacol 15 233 239 10.1089/cap.2005.15.233 15910207 (Pubitemid 40734102)
40. JG Simeon 1989 Depressive disorders in children and adolescents Psychiatr J Univ Ott 14 356 361 1:STN:280:DyaL1MzksFygtQ%3D%3D 2668989 discussion 362-363
41. MR Smucker WE Craighead LW Craighead BJ Green 1986 Normative and reliability data for the children's depression inventory J Abnorm Child Psychol 14 25 39 10.1007/BF00917219 1:STN:280:DyaL287ktFamsQ%3D%3D 3950219 (Pubitemid 16172595)
42. R Tao G Emslie T Mayes P Nakonezny B Kennard C Hughes 2009 Early prediction of acute antidepressant treatment response and remission in pediatric major depressive disorder J Am Acad Child Adolesc Psychiatry 48 1 71 78 10.1097/CHI.0b013e318190043e 19057412
43. MH Teicher CA Glod JO Cole 1993 Antidepressant drugs and the emergence of suicidal tendencies Drug Saf 8 186 212 10.2165/00002018-199308030-00002 1:STN:280:DyaK3s7pvFOjtA%3D%3D 8452661
44. EM Tsapakis F Soldani L Tondo RJ Baldessarini 2008 Efficacy of antidepressants in juvenile depression: meta-analysis Br J Psychiatry 193 1 10 17 10.1192/bjp.bp.106.031088 18700212 (Pubitemid 351946803)
45. B Vitiello S Swedo 2004 Antidepressant medications in children N Engl J Med 350 1489 1491 10.1056/NEJMp038248 1:CAS:528:DC%2BD2cXjtVeqs74%3D 15071123 (Pubitemid 38477772)
46. AL von Knorring GI Olsson PH Thomsen OM Lemming A Hulten 2006 A randomized, double-blind, placebo-controlled study of citalopram in adolescents with major depressive disorder J Clin Psychopharmacol 26 311 315 10.1097/01.jcp.0000219051.40632.d5 1:CAS:528:DC%2BD28XksFKnsbo%3D 16702897 (Pubitemid 43804624)
47. KD Wagner P Ambrosini M Rynn C Wohlberg R Yang MS Greenbaum A Childress C Donnelly D Deas 2003 Efficacy of sertraline in the treatment of children and adolescents with major depressive disorder: two randomized controlled trials JAMA 290 1033 1041 10.1001/jama.290.8.1033 1:CAS:528:DC%2BD3sXmvVSnsr4%3D 12941675 (Pubitemid 37430443)
48. KD Wagner R Berard MB Stein E Wetherhold DJ Carpenter P Perera M Gee K Davy A Machin 2004 A multicenter, randomized, double-blind, placebo-controlled trial of paroxetine in children and adolescents with social anxiety disorder Arch Gen Psychiatry 61 1153 1162 10.1001/archpsyc.61.11.1153 1:CAS:528:DC%2BD2cXhtVCitLrI 15520363 (Pubitemid 39463417)
49. KD Wagner AS Robb RL Findling J Jin MM Gutierrez WE Heydorn 2004 A randomized, placebo-controlled trial of citalopram for the treatment of major depression in children and adolescents Am J Psychiatry 161 1079 1083 10.1176/appi.ajp.161.6.1079 15169696 (Pubitemid 38735994)